✦ LIBER ✦

O-Mannosylation of recombinant human insulin-like growth factor I (IGF-I) produced in Saccharomyces cerevisiae

✍ Scribed by Karl Hård; Wilbert Bitter; Johannis P. Kamerling; Johannes F.G. Vliegenthart

Book ID: 115921677
Publisher: Elsevier Science
Year: 1989
Tongue: English
Weight: 366 KB
Volume: 248
Category: Article
ISSN: 0014-5793
DOI: 10.1016/0014-5793(89)80442-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Free insulin-like growth factors (IGF-I

Free insulin-like growth factors (IGF-I and IGF-II) in human serum

✍ Jan Frystyk; Christian Skjærbæk; Bo Dinesen; Hans Ørskov 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 875 KB

Effect of recombinant human growth hormo

Effect of recombinant human growth hormone treatment on insulin-like growth factor (IGF-I) levels in insulin-dependent diabetic patients

✍ M. I. Wurzburger; G. M. Prelevic; P. H. Sönksen; M. Wheeler; L. Balint-Peric 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 401 KB

Localization of Insulin-Like Growth Fact

Localization of Insulin-Like Growth Factor-I (IGF-I) and IGF-I Receptor (IGF-IR) in Equine Testes

✍ MJ Yoon; T Berger; JF Roser 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 922 KB

Large scale purification of recombinant

Large scale purification of recombinant insulin-like growth factor I (IGF-I, mecasermin) from a fused protein produced in Escherichia coli

✍ Hisashi Yamada; Yoshimasa Saito; Tamotsu Fujimoto; Yuji Noguchi; Toru Mori; Tosh 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 717 KB

The therapeutic potential of recombinant

The therapeutic potential of recombinant human insulin-like growth factor-I

✍ Andrew M. Cotterill 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 560 KB

Optimization of the hydroxylamine cleava

Optimization of the hydroxylamine cleavage of an expressed fusion protein to produce recombinant human insulin-like growth factor (IGF)-I

✍ Steven J. Milner; Sonia M. Thomas; F. John Ballard; Geoffrey L. Francis 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 868 KB

The application of gene fusion technology for the production of heterologous proteins in Escherichia coli has required the development of specific cleavage methods to separate the coexpressed fusion protein partner from the protein of interest. When hydroxylamine is used to cleave Asn-Gly fusion pro